Cargando…

Severe Complications After Splenic Artery Embolization for Portal Hypertension Due to Hepatic Cirrhosis

BACKGROUND: Splenomegaly/hypersplenism is one of the most common complications of portal hypertension. Splenic artery embolization (SAE) has been increasingly used for treatment of splenomegaly/hypersplenism. However, few studies focused on the severe complications after embolization. In this paper,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lei, Zhang, Zhan-Guo, Long, Xin, Liu, Fei-Long, Zhang, Wan-Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037048/
https://www.ncbi.nlm.nih.gov/pubmed/32110126
http://dx.doi.org/10.2147/RMHP.S234628
_version_ 1783500336294526976
author Zhang, Lei
Zhang, Zhan-Guo
Long, Xin
Liu, Fei-Long
Zhang, Wan-Guang
author_facet Zhang, Lei
Zhang, Zhan-Guo
Long, Xin
Liu, Fei-Long
Zhang, Wan-Guang
author_sort Zhang, Lei
collection PubMed
description BACKGROUND: Splenomegaly/hypersplenism is one of the most common complications of portal hypertension. Splenic artery embolization (SAE) has been increasingly used for treatment of splenomegaly/hypersplenism. However, few studies focused on the severe complications after embolization. In this paper, we reported 16 cases of severe complications after SAE for portal hypertension. METHODS: From February 2011 to January 2019, 16 cirrhotic patients were diagnosed with severe complications after embolization. The clinical symptoms, therapies and prognosis were analyzed. RESULTS: In these patients, the splenic embolization volume was between 50% and 70%. Among 16 cases, 7 patients were diagnosed with splenic abscess and/or left subphrenic abscess, suffered from the insistent fever, and eventually underwent the surgical therapy; 6 patients with left refractory pleural effusion, suffered from severe chest distress, and underwent repeated thoracocentesis or thoracic closed drainage; 3 patients with thrombosis in portal vein needed oral warfarin therapy. CONCLUSION: In cirrhotic patients, the severe complications after SAE are not uncommon after the procedure. It causes more suffering, prolonged hospital stay and more medical cost in these patients. It was debatable whether this technique was an appropriate technique for portal hypertension due to liver cirrhosis, patients contraindicated for the treatment should be carefully identified to avoid the complications.
format Online
Article
Text
id pubmed-7037048
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-70370482020-02-27 Severe Complications After Splenic Artery Embolization for Portal Hypertension Due to Hepatic Cirrhosis Zhang, Lei Zhang, Zhan-Guo Long, Xin Liu, Fei-Long Zhang, Wan-Guang Risk Manag Healthc Policy Original Research BACKGROUND: Splenomegaly/hypersplenism is one of the most common complications of portal hypertension. Splenic artery embolization (SAE) has been increasingly used for treatment of splenomegaly/hypersplenism. However, few studies focused on the severe complications after embolization. In this paper, we reported 16 cases of severe complications after SAE for portal hypertension. METHODS: From February 2011 to January 2019, 16 cirrhotic patients were diagnosed with severe complications after embolization. The clinical symptoms, therapies and prognosis were analyzed. RESULTS: In these patients, the splenic embolization volume was between 50% and 70%. Among 16 cases, 7 patients were diagnosed with splenic abscess and/or left subphrenic abscess, suffered from the insistent fever, and eventually underwent the surgical therapy; 6 patients with left refractory pleural effusion, suffered from severe chest distress, and underwent repeated thoracocentesis or thoracic closed drainage; 3 patients with thrombosis in portal vein needed oral warfarin therapy. CONCLUSION: In cirrhotic patients, the severe complications after SAE are not uncommon after the procedure. It causes more suffering, prolonged hospital stay and more medical cost in these patients. It was debatable whether this technique was an appropriate technique for portal hypertension due to liver cirrhosis, patients contraindicated for the treatment should be carefully identified to avoid the complications. Dove 2020-02-19 /pmc/articles/PMC7037048/ /pubmed/32110126 http://dx.doi.org/10.2147/RMHP.S234628 Text en © 2020 Zhang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhang, Lei
Zhang, Zhan-Guo
Long, Xin
Liu, Fei-Long
Zhang, Wan-Guang
Severe Complications After Splenic Artery Embolization for Portal Hypertension Due to Hepatic Cirrhosis
title Severe Complications After Splenic Artery Embolization for Portal Hypertension Due to Hepatic Cirrhosis
title_full Severe Complications After Splenic Artery Embolization for Portal Hypertension Due to Hepatic Cirrhosis
title_fullStr Severe Complications After Splenic Artery Embolization for Portal Hypertension Due to Hepatic Cirrhosis
title_full_unstemmed Severe Complications After Splenic Artery Embolization for Portal Hypertension Due to Hepatic Cirrhosis
title_short Severe Complications After Splenic Artery Embolization for Portal Hypertension Due to Hepatic Cirrhosis
title_sort severe complications after splenic artery embolization for portal hypertension due to hepatic cirrhosis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037048/
https://www.ncbi.nlm.nih.gov/pubmed/32110126
http://dx.doi.org/10.2147/RMHP.S234628
work_keys_str_mv AT zhanglei severecomplicationsaftersplenicarteryembolizationforportalhypertensionduetohepaticcirrhosis
AT zhangzhanguo severecomplicationsaftersplenicarteryembolizationforportalhypertensionduetohepaticcirrhosis
AT longxin severecomplicationsaftersplenicarteryembolizationforportalhypertensionduetohepaticcirrhosis
AT liufeilong severecomplicationsaftersplenicarteryembolizationforportalhypertensionduetohepaticcirrhosis
AT zhangwanguang severecomplicationsaftersplenicarteryembolizationforportalhypertensionduetohepaticcirrhosis